Growth Equity vs Enterprise Capital – What is the Difference?

Private equity is used to broadly group funds and funding corporations that present capital on a negotiated foundation typically to private businesses and primarily within the type of equity (i.e. stock). This class of companies is a superset that features enterprise capital, buyout-also called leveraged buyout (LBO)-mezzanine, and growth equity or growth funds. The trade expertise, amount invested, transaction construction choice, and return expectations fluctuate in keeping with the mission of each.

Enterprise capital is one of the most misused financing terms, trying to lump many perceived private investors into one category. In reality, very few companies obtain funding from enterprise capitalists-not because they are not good corporations, but primarily because they don’t fit the funding model and objectives. One enterprise capitalist commented that his agency received hundreds of enterprise plans a month, reviewed only a few of them, and invested in possibly one-and this was a large fund; this ratio of plan acceptance to plans submitted is common. Enterprise capital is primarily invested in younger companies with important progress potential. Business focus is often in technology or life sciences, though massive investments have been made in recent years in sure types of service companies. Most enterprise investments fall into one of many following segments:

· Biotechnology

· Enterprise Products and Companies

· Computer systems and Peripherals

· Client Products and Companies

· Electronics/Instrumentation

· Financial Providers

· Healthcare Services

· Industrial/Energy

· IT Providers

· Media and Entertainment

· Medical Units and Gear

· Networking and Gear

· Retailing/Distribution

· Semiconductors

· Software

· Telecommunications

As venture capital funds have grown in size, the amount of capital to be deployed per deal has increased, driving their investments into later stages…and now overlapping investments more traditionally made by progress equity investors.

Like enterprise capital funds, progress equity funds are typically limited companionships financed by institutional and high net value investors. Every are minority traders (a minimum of in concept); although in reality each make their investments in a type with terms and situations that give them effective management of the portfolio company regardless of the percentage owned. As a % of the total private equity universe, progress Physician Equity funds characterize a small portion of the population.

The primary distinction between venture capital and development equity traders is their threat profile and investment strategy. Unlike enterprise capital fund strategies, development equity buyers don’t plan on portfolio companies to fail, so their return expectations per firm could be more measured. Venture funds plan on failed investments and should off-set their losses with vital positive factors of their other investments. A results of this strategy, venture capitalists need every portfolio firm to have the potential for an enterprise exit valuation of at the very least a number of hundred million dollars if the company succeeds. This return criterion considerably limits the companies that make it by way of the opportunity filter of enterprise capital funds.

Another significant difference between progress equity traders and enterprise capitalist is that they may spend money on more traditional industry sectors like manufacturing, distribution and enterprise services. Lastly, progress equity traders could consider transactions enabling some capital to be used to fund companion buyouts or some liquidity for current shareholders; this is nearly never the case with traditional venture capital.